(Total Views: 665)
Posted On: 11/27/2022 3:52:52 AM
Post# of 153940
The conference call on the 7th will tell us how good our molecule in different indications could be...let's say....an assumption
Very nice!
But i hope Cyrus will tell us who is interested in our molecule and when he will recommence the trials again...
At this moment we know that LL works very well in the HIV/MDR population so i hope that Cyrus will tell us:
1/ when he will file the BLA for HIV/MDR again (a timeline) or the HIV/MDR indication is no longer an objective??
2/ when the hold will be lifted??
3/ when he will be our CEO??
The CC on the7th is okay but we don't need lectures but clear progress...
We already know from Nader which role our molecule can play in multiple indications..
GLTA
Very nice!
But i hope Cyrus will tell us who is interested in our molecule and when he will recommence the trials again...
At this moment we know that LL works very well in the HIV/MDR population so i hope that Cyrus will tell us:
1/ when he will file the BLA for HIV/MDR again (a timeline) or the HIV/MDR indication is no longer an objective??
2/ when the hold will be lifted??
3/ when he will be our CEO??
The CC on the7th is okay but we don't need lectures but clear progress...
We already know from Nader which role our molecule can play in multiple indications..
GLTA
(3)
(0)
